MediGuard.org, operated by iGuard Inc., monitors the safety of prescribed medicines, over-the-counter medicines and healthcare supplements. As of February 2011, there are over 2,480,000 registered users in the website.[1] The company also rates the safety of different drugs using a standardized ratings scale,[2] and has received support from advocacy groups concerned with drug adverse effects.[3]
| Company type | Private |
|---|---|
| Founded | 2007 |
| Headquarters | Princeton, New Jersey, USA |
Key people | Hugo Stephenson, CEO Elisa Cascade, Head Operations Bob Winslow, Head Medical Information |
| Products | Safety research and analysis |
| Website | http://www.mediguard.org |
The iGuard company was founded in 2007 by Hugo Stephenson, MD. It is a subsidiary of Quintiles Transnational, a multinational contract research organization.[4]
Criticism
editQualitative risk rating systems, such as that used by MediGuard, have been criticized for potentially simplifying risk assessment requirements used to inform risk management decisions.[5]
See also
edit- Boston Collaborative Drug Surveillance Program
- COSTART - Coding Symbols for a Thesaurus of Adverse Reaction Terms
- Pharmacovigilance
- Yellow Card Scheme (UK)
References
edit- ^ "Please Note: | MediGuard". www.mediguard.org. Retrieved 13 February 2011.
- ^ Barriaux, Marianne (2007-10-02). "'Traffic-light' medicine risk website to launch". The Guardian. London. Retrieved 5 May 2010.
- ^ Two Frontrunners for Drug Safety Prevention Archived 2010-12-04 at the Wayback Machine www.ismp.org, accessed 20 January 2009.
- ^ iGuard Drug Safety Alert is Newest Reason Senior Citizens, Caregivers Must Use Web SeniorJournal.com, 9 October 2007, accessed 19 November 2007.
- ^ Cox, Tony; Babayev, Djangir (2005-06-01). "Some Limitations of Qualitative Risk Rating Systems". Risk Analysis. Vol. 25, no. 3. pp. 651–662. doi:10.1111/j.1539-6924.2005.00615.x.